Case | Age | Sex | Site | Location | Size | Genetic abnormality | Characteristic feature | Recurrence | Reference |
---|---|---|---|---|---|---|---|---|---|
1 | 10 | M | back | subcutis | FUS gene rearrangement (+) by FISH | pleomorphism (+) | [1] | ||
2 | 8 | M | pelvis | subfascial | φ80mm | (−) | local recurrence and intra abdominal meta 8 mos later | [6] | |
3 | 14 | M | brachium | subfascial | φ50mm | (-) | [6] | ||
4 | 14 | M | brachium | subfascial | φ30mm | FUS gene rearrangement (+) by FISH | [6] | ||
5 | 6 | M | Lower leg | subcutis | φ10mm | EWSR1 (Ex9)/ CREB3L1 (Ex5) fusion gene by RT-PCR | (-) | [5] | |
6 | 13 | M | popliteal fossa | deep | FUS/ CREB3L1 fusion gene by array-CGH | (-) | [12] | ||
7 | 3 | M | thigh | subcutis | 17 × 16 × 12 mm | FUS gene rearrangement (+) by FISH and | unusual histology+ | recurrence 1 year later | [2] |
other chromosomal translocations (7q34, 10q11.2, 16p11.2) | calponin (+) | ||||||||
8 | 5 | M | buttock | subcutis | 29 × 17 × 25 mm | FUS gene rearrangement (+) by FISH | (+) | [7] | |
9 | 6 | F | inguinal area | φ35mm | recurrence 5 times, meta for lung 39 years later | [19] | |||
10 | 9 | M | neck | recurrence 7 times, meta 16 years later | [19] | ||||
11 | 6 | M | deltoid | φ33mm | (-) | [19] | |||
12 | 10 | F | leg | with giant rosettes | [20] | ||||
13 | 13 | F | back | (-) at 36mos | [20] | ||||
14 | 1.8 | M | cheek | φ80mm | (-) 6mo | [4] | |||
15 | 13 | F | arm | φ30mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | (-) at 34mos | [21] | ||
16 | 11 | M | axilla | φ60mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | [21] | |||
17 | 15 | M | thorax | φ30mm | FUS (Ex6)/ CREB3L1 (Ex5) fusion gene by RT-PCR | [21] | |||
18 | 13 | M | foot | φ60mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | pleural metastasis at 180, 186, and 203mos, | [21] | ||
pleuropulmonary metastasis at 228 mos | |||||||||
19 | 13 | F | abdominal wall | intramuscular | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | [13] | |||
20 | 2 | F | groin/vulva | superficial | φ20mm | (-) at 84mos | [22] | ||
21 | 3 | F | knee/popliteal fossa | superficial | φ42mm | (-) at 60mos | [22] | ||
22 | 5 | M | knee | superficial | φ40mm | (-) at 48mos | [22] | ||
23 | 6 | M | superficial | φ20mm | lost to follow up | [22] | |||
24 | 8 | M | back | superficial | φ30mm | local recurrence at 16mos, then lost to follow up | [22] | ||
25 | 10 | F | lower leg | superficial | φ16mm | (-) at 48mos | [22] | ||
26 | 13 | M | fore arm | superficial | (-) at 60mos | [22] | |||
27 | 13 | F | thigh | FUS (Ex6)-insertion-CREB3L2 (Ex5) fusion gene by RT-PCR | local recurrence at 156, 192, 228, 252, 264, | [23] | |||
and 276 mos | |||||||||
28 | 12 | F | buttock | φ30mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | lost to follow up | [23] | ||
29 | 12 | M | foot | φ30mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | local recurrence at 19mos | [23] | ||
30 | 4 | M | paravertebral | 90 × 80 × 60 mm | with giant rosettes | local recurrence at 3mos | [24] | ||
31 | 13 | M | buttock | superficial | local recurrence at 24, 36, 60mos | [25] | |||
32 | 11 | F | shoulder | deep | φ45mm | (-) 34mos | [25] | ||
33 | 14 | F | inflaclavicular | φ30mm | (-) 58mos | [26] | |||
34 | 4 | M | thigh | φ30mm | local recurrence at 6, 36, and 84mos | [27] | |||
lung metastasis at 36, 84, and 98mos | |||||||||
this case | 5 | M | Lower leg | subfascial | φ26mm | FUS (Ex6)/ CREB3L2 (Ex5) fusion gene by RT-PCR | (-) at 4 mos |